Such a REG3A-mediated mechanism of action most likely promotes induction of gp130-AMPK signaling and thus bypasses the typical impairment of insulin signaling, leading to minimization of the amount of insulin needed to control blood glucose and reduce hyperinsulinemia. Here, REG3A is linked to Hyperinsulinemia.